当前位置：首页 > 文献互助 > 互助详情

Associations of hs-CRP and D-Dimer with stroke severity and early functional outcomes in ischemic stroke: a retrospective age-stratified cohort study复制

用户mKQO0T3T2ANY 1个月前 56 10 已完结

1. 系统已在2026-03-23 18:05:29对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

SP Bhatt, H Chang, PK Joshi, MS Raja
BMC neurology, 2026
Springer
6 天前 - … High sensitivity C reactive protein and D Dimer are routinely measured biomarkers; however, their clinical relevance for early stroke severity and functional outcome, …

上一篇：Association of D-dimer and Fibrinogen Levels with Stroke Severity in Acute Ischemic Stroke Patients: A Cross-Sectional Study at a Tertiary Referral Hospital in …

下一篇：Predictive Value of Systemic Immune-Inflammation Index Combined with D-Dimer Levels and Injury Severity Score for the Prognosis of Patients with Multiple Injuries …

互助时间线

2026-03-18 09:08:24 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-03-16 18:05:29 [上传文件]

jodie0105上传了文件(pdf 919.82 KB), 求助状态变成 待确认

2026-03-16 17:11:08 [发起求助]

最新发布的求助

Biosimilars in practice: best-practice immunogenicity assessment and switching/interchangeability strategies for pharmacy-led programs 36分钟前
Protein-templated synthesis of dinucleotide repeat DNA by an antiphage reverse transcriptase 46分钟前
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors 1小时前
Design and Synthesis of USP1 Inhibitors: Synergistic Antitumor Activity with PARP Inhibitors in Triple-Negative Breast Cancer 2小时前
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders 2小时前
AutoLead: An LLM-Guided Bayesian Optimization Framework for Multi-Objective Lead Optimization 2小时前
Voltage-Gated Sodium Channels in Pain: Which Channels, Which Blockers, and Where NaV1.7 Fits 5小时前
Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC) 6小时前
Rhabdomyosarcoma spheroids with central proliferation and differentiation 6小时前
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial 6小时前
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort 7小时前
Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com